Pharmacist education in Gestational Diabetes Mellitus and its outcomes in newbor
Phase 3
- Conditions
- Health Condition 1: null- Healthy
- Registration Number
- CTRI/2017/01/007622
- Lead Sponsor
- Vineeta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 500
Inclusion Criteria
should be more than 20 years
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method improvement of knowledge of GDM mothers and knowledge improvementTimepoint: after knowledge
- Secondary Outcome Measures
Name Time Method may be hypokalemia, macrosomia , hypocalcemiaTimepoint: at delivery
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie pharmacist-led education in gestational diabetes mellitus (GDM) management?
How does pharmacist education compare to standard-of-care approaches in optimizing GDM identification and outcomes in newborns?
Are there specific biomarkers that predict maternal and neonatal outcomes in GDMIS interventional studies?
What are the potential adverse events associated with pharmacist-integrated care for gestational diabetes and how are they managed?
What combination approaches or competitor drugs are being evaluated alongside pharmacist education in GDM management trials?